Immunopathogenesis of conjunctival scarring in trachoma

Eye (Basingstoke)

Volumn 12, Issue 3, 1998, Pages 453-460

  El Asrar, Ahmed M Abu ^a   Geboes, Karel ^b   Tabbara, Khalid F ^a   Al Kharashi, Soliman A ^a   Missotten, Luc ^b   Desmet, Valeer ^b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chlamydia; Conjunctiva; Cytokines; Fibrosis; Trachoma

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; BIOPSY; CELL COUNT; CHLAMYDIA TRACHOMATIS; CLINICAL ARTICLE; CONJUNCTIVA; CONJUNCTIVA DISEASE; CONTROLLED STUDY; CYTOPLASM; CYTOTOXIC T LYMPHOCYTE; FIBROSIS; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MACROPHAGE; SCAR FORMATION; SCHOOL CHILD; SUPPRESSOR CELL; T LYMPHOCYTE; TRACHOMA;

EID: 0031851322     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.1998.104     Document Type: Article

References (57)

1. Dawson CR, Jones BR, Tarizzo ML. Guide to trachoma control in programmes for the prevention of blindness. Geneva: World Health Organization; Albany, NY: WHO Publications Centre USA [distributor], 1981.
2. Taylor HR. Trachoma and inclusion conjunctivitis. In: Strickland G, editor. Hunter’s tropical medicine. 7th ed. Philadelphia: Saunders, 1991:288-93.
3. Abu El-Asrar AM, Van den Oord JJ, Geboes K, Missotten L, Emarah MH, Desmet V. Immunopathology of trachomatous conjunctivitis. Br J Ophthalmol 1989;73:276-82.
4. Abu El-Asrar AM, Emarah MH, Van den Oord JJ, Geboes K, Desmet V, Missotten I. Conjunctival epithelial cells infected with Chlamydia trachoma tis express HLA-DR antigens [letter]. Br J Ophthalmol 1989;79:399-400.
5. Turner M, Chantry D, Buchan G, Barrett K, Feldman M. Regulation of expression of human IL-1ex and IL-1f3 genes. J Immunol 1989;143:3556-61.
6. Lonnemann G, Endres S, Van der Meer JW, Cannon JG, Koch KM, Dinarello CA. Differences in the synthesis and kinetics of release of interleukin 1 alpha (IL 1 alpha), IL 1 beta and tumor necrosis factor from human mononuclear cells. Eur J ImmunoI 1989;19:1531-6.
7. Dinarello CA. Biology of interleukin 1. FASEB J 1988;2:108-15.
8. Li DQ Tseng Sc. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol 1995;163:61-79.
9. Rothermel CD, Schachter J, Lavrich P, Lipsitz EC, Francus T. Chlamydia trachomatis-induced production of interleukin-l by human monocytes. Infect ImmunoI1989;57:2705-11.
10. Magee DM, Smith JG, Bleicker CA, Carter CJ, Bonewald LF, Schacter J, et al. Chlamydia trachoma tis pneumonia induces in vivo production of interleukin-1 and-6. Infect Immunol 1992;60:1217-20.
11. Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA. Human recombinant interleukin-l stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986;77:645-8.
12. Heckmann M, Adelmann-Grill BC, Hein R, Krieg T. Biphasic effects of interleukin-lex on dermal fibroblasts: enhancement of chemotactic responsiveness at low concentrations and of mRNA expression for collagenase at high concentrations. J Invest Dermatol 1993;100:780-4.
13. Elias JA, Freundlich B, Kern JA, Rosenbloom J. Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest 1990;97:1439-45.
14. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989;243:393-6.
15. Schmidt JA, Mezel SB, Cohen D, Green I. Interleukin-1, a potential regulator of fibroblast proliferation. J Immunol 1982;128:2177-82.
16. Zhang Y, Lee TC, Guillemin B, Yu MC, Rom WN. Enhanced IL-lf3 and tumor necrosis factor-ex release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 1993;150:4188-96.
17. Kline IN, Schwartz DA, Monick MM, Floerchinger CS, Hunninghake GW. Relative release of interleukin-lf3 and interleukin-l receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis. Chest 1993;104:47-53.
18. Rameshwar P, Denny TN, Stein D, Gascon P. Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines: potential role for interleukin-l and TGF-f3. J ImmunoI 1994;153:2819-30.
19. Kawanami O, Jiang HX, Mochimaru H, Yoneyama H, Kudoh S, Ohkuni H, et al. Alveolar fibrosis and capillary alteration in experimental pulmonary silicosis in rats. Am J Respir Crit Med 1995;151:1946-55.
20. Franko AJ, Sharplin J. Development of fibrosis after lung irradiation in relation to inflammation and lung function in a mouse strain prone to fibrosis. Radiat Res 1994;140:347-55.
21. Hinglais N, Heudes D, Nicoletti A, Mandet C, Laurent M, Bariety J, et al. Colocalization of mycocardial fibrosis and inflammatory cells in rats. Lab Invest 1994;70:286-94.
22. Wahl SM. The role of lymphokines and monokines in fibrosis. Ann N Y Acad Sci 1985;460:224-31.
23. Levitt D, Danen R, Bard J. Both species of Chlamydia and two biovars of Chlamydia trachoma tis stimulate mouse B lymphocytes. J ImmunoI1986;136:4249-54.
24. Levitt D, Danen R. Development and regulation of Chlamydia-responsive murine B lymphocytes. J Immunol 1987;138:3468-74.
25. Burd EM, Tabbara KF, Nasr AM, Taylor PB. Conjunctival lymphocyte subsets in trachoma. Int Ophthalmol 1988;12:53-7.
26. Reacher MH, Pe’er J, Rapoza PA, Whittum-Hudson JA, Taylor HR. T cells and trachoma: their role in cicatricial disease. Ophthalmology 1991;98:334-41.
27. Wahl SM, Hunt DA, Allen JB, Wilder RL, Paglia WL, Hand AR. Bacterial cell wall-induced hepatic granulomas: an in vivo model of T cell-dependent fibrosis. J Exp Med 1986;163:884-902.
28. Barbul A. Role of T cell-dependent immune system in wound healing. Prog Clin Bioi Res 1988;266:161-75.
29. Wahl SM, Allen JB. Tlymphocyte-dependent mechanisms of fibrosis. Prog Clin Bioi Res 1988;266:147-60.
30. Kovacs EJ, Di Pietro LA. Fibrogenic cytokines and connective tissue production. FASEB J 1994;8:854-61.
31. Su H, Caldwell HD. CD4 T cells play a significant role in adaptive immunity to Chlamydia trachoma tis infection of the mouse genital tract. Infect Immun 1995;63:3302-8.
32. Igietseme JU, Ramsey KH, Magee DM, Williams DM, Kincy TJ, Rank RG. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific Thl lymphocyte clone. Reg Immunol 1993;5:317-24.
33. Igietseme JU, Magee DM, Williams DM, Rank RG. Role for CDs + T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones. Infect Immun 1994;63:5195-7.
34. Starnbach MN, Bevan MJ, Lampe MF. Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J Immunol 1994;153:5183-9.
35. Fitzpatrick DR, Wie J, Webb D, Bonfiglioli R, Gardner ID, Mathews JD, et al. Preferential binding of Chlamydia trachomatis to subsets of human lymphocytes and induction of interleukin-6 and interferon-gamma. Immunol Cell Bioi 1991;69:337-48.
36. Summersgill JT, Sahney NN, Gaydos CA, Quinn TC, Ramirez JA. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect lmmun 1995;63:2801-3.
37. McCafferty MC, Maley SW, Entrican G, Buxton D. The importance of interferon-y in an early infection of Chlamydia psittaci in mice. Immunology 1994;81:631-6.
38. Byrne GI, Grubbs B, Marshall TJ, Schachter J, Williams DM. Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection. Infect Immun 1988;56:2023-7.
39. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev ImmunoI1989;7:145-73.
40. Cain TK, Rank RG. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 1995;63:1784-9.
41. Simon AK, Seipelt E, Wu P, Wenzel B, Braun J, Sieper J. Analysis of cytokine profiles in synovial T cell clones from Chlamydia reactive arthritis patients: predominance of the Th1 subset. Clin Exp Immunol 1993;94:122-6.
42. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL. Repeated Chlamydia trachoma tis infection of Macaca nemestrina fallopian tubes produce a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun 1997;65:2175-82.
43. Abu EI-Asrar AM, Van den Oord JJ, Billiau A, Desmet V, Emarah MH, Missotten L. Recombinant interferon-gamma induces HLA-DR expression on human corneal epithelial and endothelial cells in vitro: a preliminary report. Br J Ophthalmol 1989;73:587-90.
44. Callahan GN. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells. J Immunol 1984;132:2649-57.
45. Hernandez-Pando R, Orozcoe H, Sampieri A, Povon L, Velasquillo C, Larriva-Sahd J, et al. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 1996;89:26-33.
46. Manor E, Sarov I. Inhibition of Chlamydia trachomatis replication in HEp-2 cells by human monocyte-derived macrophages. Infect Immun 1988;56:3280-4.
47. Williams DM, Bonewald LF, Roodman GD, Byrne GI, Magee DM, Schachter J. Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection. Infect Immun 1989;57:1351-5.
48. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet derived growth factor. Cells 1986;46:155-69.
49. Westermark B. The molecular and cellular biology of platelet-derived growth factor. Acta Endocrinol 1990;123:131-42.
50. Grotendorst GR, Seppa HE, Kleinman HK, Martin GR. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Nat! Acad Sci USA 1981;78:3669-72.
51. Seppa HE, Grotendorst GR, Seppa S, Schiffmann E, Martin GR. Platelet-derived growth factor is chemotactic for fibroblasts. J Cell Bioi 1982;92:584-8.
52. Martinet Y, Rom WR, Grothendorst GR, Martin GR, Crystal RG. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med 1987;317:202-9.
53. Nagaoka I, Trapnell Be, Crystal RG. Upregulation of platelet-derived growth Factor-A and-B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. J Clin Invest 1990;85:2023-7.
54. Harmon KR, Witkop CJ, White JG, King RA, Peterson M, Moore D, et al. Pathogenesis of pulmonary fibrosis: plateletderived growth factor precedes structural alterations in the Hermansky-Pudlak syndrome. J Lab Clin Med 1994;123:617-27.
55. Antoniades HN, Bravo MA, Avila RE, Galanopoulos T, Neville-Golden J, Maxwell M, et al. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 1990;86:1055-64.
56. Phan SH, Kunkel SL. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 1992;18:29-43.
57. Everson MP, Chandler DB. Changes in distribution, morphology, and tumor necrosis factor-IT secretion of alveolar macrophage subpopulations during the development of bleomycin-induced pulmonary fibrosis. Am J Pathol 1992;140:503-12.